Aurobindo Receives Warning Letter After Form 483
The US Food and Drug Administration has issued Aurobindo with a warning letter for an API site, shortly after one of its formulations plants received yet another Form 483, with ten observations.
The US Food and Drug Administration has issued Aurobindo with a warning letter for an API site, shortly after one of its formulations plants received yet another Form 483, with ten observations.